Profilo
Dr. Eric von Hofe is a Vice President at Generex Biotechnology Corp.
and a Chief Executive Officer at CellXLife.
Dr. von Hofe was previously employed as a President & Chief Operating Officer by Affyimmune Therapeutics, Inc., a Director-New Targets by Idera Pharmaceuticals, Inc., a Director-Programs & Operations by Millennium Pharmaceuticals, Inc., a President & Chief Scientific Officer by NuGenerex Immuno-Oncology, Inc., and an Assistant Professor-Pharmacology by University of Massachusetts.
He received his doctorate degree from the University of Southern California.
Posizioni attive di Eric von Hofe
| Società | Posizione | Inizio |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Precedenti posizioni note di Eric von Hofe
| Società | Posizione | Fine |
|---|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Presidente | - |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Presidente | - |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | - |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Direttore operativo | - |
Formazione di Eric von Hofe
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Generex Biotechnology Corp.
Generex Biotechnology Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and commercialization of drug delivery systems & technologies | Commercial Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products and vaccines for the treatment of cancer diseases | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Commercial Services |
















